✦ LIBER ✦

History and New Developments. Pharmacology of 5-HT3 Antagonists

✍ Scribed by Andre Rex; Bettina Bert; Heidrun Fink

Publisher: John Wiley and Sons
Year: 2007
Weight: 11 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200747268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacological eff

Pharmacokinetics and pharmacological effect of lerisetron, a new 5-HT3 antagonist, in rats

✍ Nerea Jauregizar; Rosario Calvo; Elena Suarez; Antonio Quintana; Ewa Raczka; Joh 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

ChemInform Abstract: New 2-Piperazinylbe

ChemInform Abstract: New 2-Piperazinylbenzimidazole Derivatives as 5-HT3 Antagonists. Synthesis and Pharmacological Evaluation.

✍ A. ORJALES; R. MOSQUERA; L. LABEAGA; R. RODES 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 1 views

Pharmacological properties of dolasetron

Pharmacological properties of dolasetron, a potent and selective antagonist at 5-HT3 receptors

✍ Robert C. Miller; Martin Galvan; Maurice W. Gittos; Paul L. M. van Giersbergen; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

L-683,877: Pharmacological profile of a

L-683,877: Pharmacological profile of a novel 5-HT3 receptor antagonist

✍ Dr. David Tattersall; Nigel Newberry; Margaret S. Beer; Mike Rigby; Michael Gilb 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Zatosetron, a selective 5-HT3 receptor a

Zatosetron, a selective 5-HT3 receptor antagonist: Pharmacological activities of human and animal metabolites

✍ Marlene L. Cohen; William Bloomquist; Christopher R. Schmid; David W. Robertson; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

## Abstract Zatosetron is a potent, orally active 5‐HT~3~ receptor antagonist with a long duration of activity in laboratory animals and humans. Several metabolites have been detected in plasma and urine of humans and experimental animals receiving zatosetron. The present study was designed to expl

Pharmacology of the human metabolites of

Pharmacology of the human metabolites of dolasetron, an antiemetic 5-HT3 receptor antagonist

✍ Marc Bigaud; Jack Elands; Philip R. Kastner; Rick A. Bohnke; Lee W. Emmert; Mart 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB